FLO9 Antibody

What is FLO9 and what is its function in Saccharomyces cerevisiae?

FLO9 (P39712) is a cell wall protein belonging to the flocculin family in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508/S288c). It functions as a lectin-like cell wall protein that plays a critical role in cell-cell adhesion processes, particularly flocculation - the asexual aggregation of yeast cells. FLO9 contributes to the formation of multicellular pseudohyphae and biofilms, which are important adaptive responses to environmental changes. The protein contains characteristic serine/threonine-rich repeats that undergo extensive glycosylation, contributing to its adhesive properties in the cell wall matrix .

How does FLO9 relate to other flocculin family proteins?

FLO9 belongs to the FLO gene family that includes FLO1, FLO8, and FLO11, all of which encode cell wall proteins involved in cellular adhesion processes. While sharing structural similarities, each protein exhibits distinct expression patterns and regulatory mechanisms. FLO9 shares the highest sequence homology with FLO1 (approximately 94% identity), suggesting potential functional redundancy, yet research indicates distinct roles in flocculation timing and intensity. The various FLO proteins contain N-terminal domains responsible for carbohydrate binding, central repeat domains that determine adhesion strength, and C-terminal regions with GPI-anchor attachment sites that secure the proteins to the cell wall .

What are the characteristics of FLO9 Antibody?

FLO9 Antibody (CSB-PA336614XA01SVG) is a research-grade immunological reagent developed against the FLO9 protein of Saccharomyces cerevisiae. This antibody is designed to specifically recognize and bind to epitopes on the FLO9 protein, allowing researchers to detect, quantify, and isolate this protein in various experimental contexts. The antibody is available in two volume formats (2ml/0.1ml) and has been validated for specificity against the target Uniprot accession P39712. As with other research antibodies, it enables visualization of protein expression, localization, and interaction patterns in yeast cellular systems .

What are the recommended applications for FLO9 Antibody?

FLO9 Antibody can be employed in multiple research applications including Western blotting, immunoprecipitation, immunofluorescence microscopy, flow cytometry, and chromatin immunoprecipitation. For optimal results in Western blotting, researchers should use 1:500-1:2000 dilutions, while immunofluorescence applications typically require 1:50-1:200 dilutions. Each application requires specific optimization to account for sample preparation methods, buffer compositions, and detection systems. The antibody performs particularly well in detecting native and denatured forms of FLO9 in yeast cell wall extracts, whole cell lysates, and subcellular fractions .

How should I optimize Western blot protocols for FLO9 Antibody?

Optimization of Western blot protocols for FLO9 Antibody requires careful consideration of several parameters. Begin with sample preparation using methods that effectively solubilize cell wall proteins, such as hot SDS extraction or enzymatic digestion with β-glucanases. Given the heavily glycosylated nature of FLO9, consider deglycosylation treatments to improve resolution. Use 8-10% polyacrylamide gels to accommodate the high molecular weight of FLO9. Transfer to PVDF membranes at lower voltages (15V) for extended periods (overnight) to ensure efficient transfer of high molecular weight glycoproteins. Block with 5% non-fat milk or BSA in TBS-T for 1-2 hours at room temperature. Incubate with primary antibody (1:1000 dilution) overnight at 4°C, followed by appropriate HRP-conjugated secondary antibody incubation for 1 hour at room temperature. Enhanced chemiluminescence detection typically provides the best results for visualizing FLO9 bands .

What controls should be included when using FLO9 Antibody?

When designing experiments with FLO9 Antibody, inclusion of appropriate controls is essential for result validation and interpretation. Positive controls should include wild-type S. cerevisiae strains known to express FLO9, while negative controls should utilize flo9Δ deletion mutants or strains where FLO9 expression is repressed. Additionally, pre-incubation of the antibody with purified FLO9 protein or peptide should abolish specific signals, serving as an antibody neutralization control. When assessing cross-reactivity, particularly with the highly homologous FLO1, include samples from strains with differential expression of FLO family members. For loading controls in Western blots, antibodies against stable yeast proteins such as actin (ACT1) or tubulin (TUB1) should be employed to normalize for protein quantity variations .

Why might I observe non-specific binding or background with FLO9 Antibody?

Non-specific binding when using FLO9 Antibody can arise from several sources. The high homology between FLO family proteins (particularly FLO1 and FLO9) may result in cross-reactivity, especially in strains with high expression of multiple FLO genes. Additionally, the extensive glycosylation of FLO proteins can create variable epitope accessibility and non-uniform banding patterns. Highly mannose-rich yeast cell wall extracts may cause background due to weak interactions with antibody carbohydrate-binding domains. To reduce non-specific binding, increase blocking reagent concentration to 5-10%, extend blocking times to 2 hours at room temperature, use more stringent washing protocols (0.1-0.3% Tween-20 in TBS), and optimize antibody dilutions. Pre-adsorption of the antibody with yeast cell wall extract from flo9Δ strains may also reduce background. For immunofluorescence applications, autofluorescence from yeast cell walls can be minimized by including a quenching step with 0.1% sodium borohydride prior to antibody incubation .

How can I improve detection sensitivity for FLO9?

Enhancing detection sensitivity for FLO9 requires optimization at multiple experimental stages. During sample preparation, use protease inhibitor cocktails specific for yeast proteins to prevent degradation, and consider cell wall digestion methods that preserve native epitopes. For Western blotting, signal amplification systems such as biotin-streptavidin detection or polymer-based detection reagents can increase sensitivity by 5-10 fold compared to conventional secondary antibodies. Longer primary antibody incubation times (overnight at 4°C) at optimal dilutions (typically 1:500-1:1000) often yield better results than shorter incubations at higher concentrations. For immunofluorescence, signal enhancement can be achieved using tyramide signal amplification systems or quantum dot-conjugated secondary antibodies. In all applications, reducing background through optimized blocking and washing steps will improve signal-to-noise ratios and enhance detection of low-abundance FLO9 protein .

What should I consider when studying FLO9 expression across different growth conditions?

When investigating FLO9 expression under varying growth conditions, several factors must be taken into account. FLO gene expression shows significant strain-specific variation and is highly responsive to environmental conditions including nitrogen availability, carbon source, pH, and growth phase. Standardize culture conditions regarding media composition, inoculation density, aeration rates, and harvesting times. Employ quantitative methods such as qRT-PCR to measure transcript levels alongside protein detection. Remember that post-transcriptional regulation may result in discrepancies between mRNA and protein levels. For growth condition comparison studies, extract proteins using consistent methods and normalize loading by total protein content or reliable housekeeping proteins. Consider the potential for epigenetic regulation, as FLO genes are often subject to position-dependent expression variations and silencing. Document colony morphology and flocculation behavior alongside molecular analyses for phenotype-genotype correlation .

How can FLO9 Antibody be used in cellular localization studies?

For cellular localization studies, FLO9 Antibody can be employed in immunofluorescence microscopy with optimized protocols. Fix yeast cells with 4% paraformaldehyde for 30 minutes followed by cell wall digestion with zymolyase (0.5-1 U/ml) for 20-30 minutes to improve antibody accessibility while maintaining cell morphology. Permeabilize with 0.1% Triton X-100 for 5 minutes, block with 3% BSA in PBS for 1 hour, then incubate with FLO9 Antibody at 1:100 dilution overnight at 4°C. After washing, apply fluorophore-conjugated secondary antibodies (1:500) for 1 hour at room temperature, counterstain with DAPI (1 μg/ml) to visualize nuclei, and mount in anti-fade medium. For co-localization studies, combine FLO9 Antibody with markers for cell wall structures (ConA, WGA), secretory pathway components, or other cell wall proteins. Confocal microscopy with z-stack acquisition is recommended for precise localization due to the three-dimensional nature of yeast cell walls. Super-resolution techniques such as STORM or PALM can provide detailed insights into FLO9 distribution patterns at nanometer resolution .

What insights can chromatin immunoprecipitation with FLO9 Antibody provide?

Chromatin immunoprecipitation (ChIP) using FLO9 Antibody represents an advanced application that can reveal insights into gene regulation mechanisms. While primarily used for detecting FLO9 protein, modified ChIP protocols can investigate transcription factors that bind to the FLO9 promoter region, such as Flo8p, Sfl1p, and Mss11p. For such experiments, crosslink yeast cells with 1% formaldehyde for 15 minutes, lyse cells using glass bead disruption in appropriate buffers containing protease inhibitors, sonicate to generate 200-500bp DNA fragments, then immunoprecipitate using antibodies against the transcription factors of interest. qPCR analysis with primers specific to the FLO9 promoter region can quantify enrichment. This approach can elucidate how environmental signals are integrated into transcriptional responses affecting FLO9 expression. Combined with RNA-seq or proteomics data, ChIP results can provide comprehensive understanding of the regulatory networks controlling FLO9 and related adhesion phenotypes in response to changing environments .

How has FLO9 research contributed to understanding biofilm formation?

Research utilizing FLO9 Antibody has significantly advanced our understanding of yeast biofilm formation processes. Studies have demonstrated that FLO9 expression correlates with specific stages of biofilm development, particularly during the maturation phase when cell-cell adhesion strengthens the biofilm structure. Using the antibody in immunofluorescence studies of developing biofilms has revealed heterogeneous expression patterns within the community, with higher expression in peripheral cells compared to those in the biofilm core. Quantitative Western blot analyses across biofilm development timepoints have shown that FLO9 expression peaks during the late exponential growth phase before declining in mature biofilms. This temporal expression pattern differs from other flocculins like FLO11, which maintains high expression throughout biofilm maturation. These findings suggest specialized roles for different FLO proteins in biofilm architecture and development. Additionally, comparative studies between planktonic and biofilm growth states using FLO9 Antibody have identified post-translational modifications specific to biofilm-associated FLO9, indicating condition-specific protein processing that may impact adhesion properties .

What are the optimal parameters for FLO9 Antibody applications?

How do I troubleshoot common issues with FLO9 Antibody experiments?

What expression patterns have been documented for FLO9 across laboratory conditions?